The Department of Pharmacogenomics is a specialized scientific department focused on studying the impact of genetic variations on individuals’ drug responses, aiming to enhance drug efficacy, minimize adverse effects, and achieve precision medicine. The Department is dedicated to providing the necessary educational and research environment for postgraduate studies, enabling students and researchers to perform at their best through the application of pharmacogenomics and individual genetic information to determine the right drug, at the right dose, at the right time. The Department also contributes to the development of advanced academic and research programs and prepares scientific and research personnel capable of handling genetic data and analyzing drug responses. This supports the improvement of treatment protocols and the development of personalized drug strategies based on genetic information. Additionally, the Department is committed to producing high-quality research outputs that foster medical innovation and precision medicine, thereby enhancing the University’s role in serving the healthcare sector and supporting the national goals of Saudi Vision 2030 in advancing data-driven, innovative healthcare.
For More
Organizational structure
Institute Administration
Partnerships and Agreements
Social Responsibility and Community Service
Search King Abdulaziz University